Shulman DeMeo Asset Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$240K Hold
616
0.04% 122
2026
Q1
$292K Buy
616
+1
+0.2% +$503 0.06% 107
2025
Q4
$287K Hold
615
0.07% 95
2025
Q3
$262K Sell
615
-16
-3% -$6.2K 0.06% 102
2025
Q2
$242K Buy
631
+1
+0.2% +$360 0.06% 102
2025
Q1
$218K Buy
+630
New +$203K 0.06% 105
2024
Q4
Sell
-645
Closed -$262K 127
2024
Q3
$262K Buy
645
+1
+0.2% +$366 0.06% 111
2024
Q2
$207K Sell
644
-8
-1% -$2.6K 0.05% 116
2024
Q1
$218K Buy
+652
New +$199K 0.06% 120
2023
Q3
Sell
-858
Closed -$260K 130
2023
Q2
$260K Sell
858
-97
-10% -$27K 0.08% 103
2023
Q1
$252K Hold
955
0.08% 108
2022
Q4
$229K Buy
+955
New +$214K 0.08% 113
2022
Q2
Sell
-980
Closed -$246K 140
2022
Q1
$246K Hold
980
0.07% 125
2021
Q4
$252K Buy
+980
New +$240K 0.07% 124
2021
Q3
Sell
-980
Closed -$203K 103
2021
Q2
$203K Buy
+980
New +$200K 0.08% 62

Other funds holding HCA

Shulman DeMeo Asset Management's HCA Position: Q2 2026 in Review

Shulman DeMeo Asset Management held its HCA Healthcare (HCA) position steady in Q2 2026 at 616 shares worth $240K. The position accounts for 0.04% of the portfolio, ranked #122.

Shulman DeMeo Asset Management first reported a position in HCA in Q2 2021 and has held it in 15 quarters since. The position peaked at $292K in Q1 2026. 307 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Shulman DeMeo Asset Management held 616 shares of HCA Healthcare worth $240K as of Q2 2026.
  • Shulman DeMeo Asset Management left its HCA Healthcare share count unchanged in Q2 2026.
  • HCA Healthcare made up 0.04% of Shulman DeMeo Asset Management's portfolio in Q2 2026, its #122 holding.
  • Shulman DeMeo Asset Management first reported a position in HCA Healthcare in Q2 2021 and has held it in 15 quarters since.
  • Shulman DeMeo Asset Management's HCA Healthcare position peaked at $292K in Q1 2026.
  • 307 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Shulman DeMeo Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.